Scarica l'app Stockscreener
26.69
2.30%
0.60
Pre-mercato:
26.41
-0.28
-1.05%
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
Balance Sheet Breakdown: Edgewise Therapeutics Inc (EWTX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
How did Edgewise Therapeutics Inc (EWTX) fare last session? - US Post News
The Potential Rise in the Price of Edgewise Therapeutics Inc (EWTX) following insiders activity - Knox Daily
Perceptive Advisors LLC Sells 463,229 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Frazier Life Sciences Management L.P. Buys 427,500 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Duchenne Muscular Dystrophy Treatment Drugs, Clinical Trials, Pipeline Insights and Companies 2024 - The Globe and Mail
Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge - Benzinga
Analyst Think There's Still Time to Get in on Edgewise, Up 332% - MSN
Edgewise Therapeutics Inc (EWTX)’s Market Momentum: Closing Strong at 25.92, Down -2.15 - The Dwinnex
Analysts Think There's Still Time to Get in on Edgewise, Up 332% - MarketBeat
Bristol-Myers Squibb Company (BMY-N) QuotePress Release - The Globe and Mail
This trade activity should not be overlooked: Edgewise Therapeutics Inc (EWTX) - SETE News
Edgewise Therapeutics general counsel sells over $1.9m in company stock By Investing.com - Investing.com South Africa
Insider Selling: Edgewise Therapeutics, Inc. (NASDAQ:EWTX) General Counsel Sells 50,000 Shares of Stock - Defense World
Alan J. Russell Sells 75,000 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stock - Defense World
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) General Counsel Sells $578,074.86 in Stock - Defense World
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) CMO Joanne M. Donovan Sells 7,162 Shares - Defense World
R Michael Carruthers Sells 125,092 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stock - Defense World
Edgewise Therapeutics CMO sells $202k in company stock By Investing.com - Investing.com South Africa
Edgewise Therapeutics CFO sells over $3.5 million in company stock By Investing.com - Investing.com South Africa
Edgewise Therapeutics CFO sells over $3.5 million in company stock By Investing.com - Investing.com Canada
Edgewise Therapeutics executive sells over $1.2m in stock By Investing.com - Investing.com Canada
Edgewise Therapeutics CSO sells over $2 million in company stock By Investing.com - Investing.com Canada
Edgewise Therapeutics CSO sells over $2 million in company stock - Investing.com
Edgewise Therapeutics CMO sells $202k in company stock - Investing.com India
Edgewise Therapeutics CMO sells $202k in company stock By Investing.com - Investing.com Australia
Edgewise Therapeutics CMO sells $202k in company stock - Investing.com
Edgewise Therapeutics CFO sells over $3.5 million in company stock - Investing.com
Edgewise Therapeutics CSO sells over $2 million in company stock By Investing.com - Investing.com UK
Edgewise Therapeutics CMO sells $202k in company stock By Investing.com - Investing.com UK
Edgewise Therapeutics - The Pharma Letter
Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 6.9% - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Down 6.9% - Defense World
Edgewise Therapeutics Inc (EWTX) produces promising results - US Post News
46,234 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Acquired by Federated Hermes Inc. - Defense World
Federated Hermes Inc. Takes Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? - Benzinga
Why Edgewise Therapeutics Stock Is Up 50% on Thursday - MSN
Edgewise Therapeutics (NASDAQ:EWTX) Hits New 1-Year High After Analyst Upgrade - Defense World
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Bought by American Century Companies Inc. - Defense World
Edgewise Therapeutics (NASDAQ:EWTX) Hits New 52-Week High Following Analyst Upgrade - Defense World
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Bought by American Century Companies Inc. - MarketBeat
Rhumbline Advisers Purchases 14,041 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Edgewise Therapeutics (NASDAQ:EWTX) Shares Gap Up to $18.08 - Defense World
Edgewise Therapeutics Inc [EWTX] stock Initiated by Piper Sandler analyst, price target now $48 - The DBT News
Edgewise’s Early Cardiomyopathy Data Builds Case For A Blockbuster - Scrip
Edgewise shares jump after positive heart drug data - The Pharma Letter
Edgewise Therapeutics Shares Soar 50% on Promising Early Data for HCM Drug EDG-7500 - Zenopa
Edgewise Therapeutics (NASDAQ:EWTX) Price Target Raised to $33.00 at Truist Financial - Defense World
Edgewise’s EDG-7500 shows benefit in two obstructive HCM trials - Clinical Trials Arena
Edgewise’s EDG-7500 shows benefit in two obstructive HCM trials - Yahoo Finance
Quest Partners LLC Has $31,000 Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Edgewise's stock jumps 50% on the back of safety data for potential heart disease rival to Camzyos - Fierce Biotech
Edgewise Therapeutics Target of Unusually Large Options Trading (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics Sees Unusually High Options Volume (NASDAQ:EWTX) - Defense World
Edgewise reports positive trial results for heart disease drug By Investing.com - Investing.com Canada
Edgewise Therapeutics (EWTX) Experiences Stock Boost After Revealing Successful Trial Data - Stocks Telegraph
Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge - sharewise
4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate - AOL
Edgewise: Stock Is Bouncing On Heart Disease Drug Data, Albeit From Just 7 Patients (Rating Upgrade) - Seeking Alpha
Top 2% Biotech Hits Slam Dunk On Bid To Edge Out Bristol, Cytokinetics - Investor's Business Daily
Truist Financial Increases Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $33.00 - MarketBeat
Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge - MarketBeat
Edgewise Therapeutics price target raised to $42 from $32 at Leerink - TipRanks
Why Edgewise Therapeutics Stock Is Up 50% on Thursday - Yahoo Finance
EWTX Stock Soars on Upbeat Efficacy Data From Cardiomyopathy Studies - Zacks Investment Research
EWTX Stock Soars on Upbeat Efficacy Data From Cardiomyopathy Studies - Yahoo Finance
Edgewise Therapeutics jumps on early data for heart disease drug - xm.com
Edgewise Therapeutics (NASDAQ:EWTX) Sets New 52-Week High at $27.51 - MarketBeat
Edgewise reports positive trial results for heart disease drug By Investing.com - Investing.com Australia
Edgewise reports positive trial results for heart disease drug - Investing.com India
Edgewise Therapeutics Stock Shoots Higher On Promising Early Results For Thickened Heart Treatment - Benzinga
0.05%
4.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):